MacelaCarolina Research Institute for MedicinesPortugal

MacelaCarolina
Carolina is a Master’s student in Biopharmaceutical Sciences at the Faculty of Pharmacy, University of Lisbon. She is currently developing her thesis at the BioNanoSciences – Drug Delivery & Immunoengineering Lab (iMed.ULisboa), focusing on the impact of lymphatic vasculature normalization in metastatic breast cancer, using clinically relevant 3D and immunocompetent mouse models.

Tuesday, 17 June 2025

Time Session
09:20
10:55
BaggioliniArianna Co-Chair Switzerland
JoyceJohanna A Co-Chair Switzerland
  • Identifying and targeting metabolic vulnerabilities in leptomeningeal metastasis
    BoireAdrienne Speaker United States
  • Proffered Paper: Reshaping Tumor-Vascular-Immune Crosstalk by VEGFR-3 Modulation in Breast Cancer Brain Metastases
    EACR25-1283
    MacelaCarolina Presenter Portugal
  • Strategies to challenge brain metastases in mice and human
    ValienteManuel Speaker Spain
  • Proffered Paper: Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3
    EACR25-1678
    SeehawerMarco Presenter United States
  • Unraveling the Complexity of Cancer Ecosystems
    JoyceJohanna A Speaker Switzerland
Auditorium II